Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.

AACR 2021

AACR 2021: Study shows young early-onset colorectal cancer patients have increased survival

AACR 2021: Study shows young early-onset colorectal cancer patients have increased survival

AACR 2021: Study provides new insights into resistance to immune checkpoint inhibitors

AACR 2021: Study provides new insights into resistance to immune checkpoint inhibitors

AACR 2021: Researchers identify surface protein as a new osteosarcoma therapeutic target for antibody-drug conjugates

AACR 2021: Researchers identify surface protein as a new osteosarcoma therapeutic target for antibody-drug...

AACR 2021: Cancer-killing virus therapy shows promise against inoperable skin cancers

AACR 2021: Cancer-killing virus therapy shows promise against inoperable skin cancers

AACR 2021: Ovarian cancer patients face increased risk of mental illness

AACR 2021: Ovarian cancer patients face increased risk of mental illness

AACR 2021: Immunotherapy response prediction using tumour mutational burden may differ between men and women with melanoma

AACR 2021: Immunotherapy response prediction using tumour mutational burden may differ between men and women with...

AACR 2021: Liquid biopsy augments MRI for predicting response to neoadjuvant treatment in patients with breast cancer

AACR 2021: Liquid biopsy augments MRI for predicting response to neoadjuvant treatment in patients with breast...

AACR 2021: CREB1 identified as potential therapeutic target for the treatment of pancreatic cancer

AACR 2021: CREB1 identified as potential therapeutic target for the treatment of pancreatic cancer

AACR 2021: Personalised cancer vaccine given after adjuvant therapy safe, shows early efficacy in multiple tumour types

AACR 2021: Personalised cancer vaccine given after adjuvant therapy safe, shows early efficacy in multiple tumour...

AACR 2021: Level of chromosomal abnormality in lung cancer may predict immunotherapy response

AACR 2021: Level of chromosomal abnormality in lung cancer may predict immunotherapy response

AACR 2021: Therapeutics Discovery researchers identify key biomarker for metabolic inhibitor

AACR 2021: Therapeutics Discovery researchers identify key biomarker for metabolic inhibitor

AACR 2021: The impact of chemotherapy on immune cells in the tumour microenvironment

AACR 2021: The impact of chemotherapy on immune cells in the tumour microenvironment

AACR 2021: Researchers identify key biomarker for metabolic inhibitor

AACR 2021: Researchers identify key biomarker for metabolic inhibitor

AACR 2021: Combining dabrafenib and trametinib to treat BRAF V600E-mutant high-grade (HGG) and low-grade glioma (LGG) shows significant antitumour activity

AACR 2021: Combining dabrafenib and trametinib to treat BRAF V600E-mutant high-grade (HGG) and low-grade glioma...

AACR2021: Early-onset colorectal cancers from patients of different races may exhibit distinct genetic features

AACR2021: Early-onset colorectal cancers from patients of different races may exhibit distinct genetic features

AACR 2021: FDA-approved selpercatinib shows clinical benefits for RET fusion-positive cancers beyond lung and thyroid cancers

AACR 2021: FDA-approved selpercatinib shows clinical benefits for RET fusion-positive cancers beyond lung and...

AACR 2021: Novel approach to PRMT5 inhibition that selectively targets the PRMT5/MTA complex in MTAP-deleted cancer models

AACR 2021: Novel approach to PRMT5 inhibition that selectively targets the PRMT5/MTA complex in MTAP-deleted...

AACR 2021: Healthy lifestyle may offset risk of lethal prostate cancer in men with high genetic risk

AACR 2021: Healthy lifestyle may offset risk of lethal prostate cancer in men with high genetic risk

AACR 2021: Unselected autologous tumour infiltrating lymphocyte therapy shows early promise in patients with metastatic melanoma

AACR 2021: Unselected autologous tumour infiltrating lymphocyte therapy shows early promise in patients with...

AACR 2021: Rare pathogenic germline variants were observed in sporadic paediatric neuroblastoma cases and were inherited

AACR 2021: Rare pathogenic germline variants were observed in sporadic paediatric neuroblastoma cases and were...

AACR 2021: Neoadjuvant nivolumab plus chemotherapy increased pathological complete response rate in CheckMate-816 lung cancer trial

AACR 2021: Neoadjuvant nivolumab plus chemotherapy increased pathological complete response rate in CheckMate-816...

$AACR 2021: Bispecific CAR T-cell therapy shows early promise for relapsed or refractory B-cell lymphoma$

AACR 2021: Bispecific CAR T-cell therapy shows early promise for relapsed or refractory B-cell lymphoma

AACR 2021: Bispecific fusion protein tebentafusp significantly improves overall survival in patients with metastatic uveal melanoma

AACR 2021: Bispecific fusion protein tebentafusp significantly improves overall survival in patients with...

AACR 2021: Oncolytic herpesvirus shows early promise in paediatric patients with high-grade glioma

AACR 2021: Oncolytic herpesvirus shows early promise in paediatric patients with high-grade glioma

AACR 2021: Immunotherapy combination shows early promise in aggressive brain cancers

AACR 2021: Immunotherapy combination shows early promise in aggressive brain cancers

AACR 2021: Resistance to immunotherapy in patients with urothelial bladder cancer is traced to specific sets of immune cells

AACR 2021: Resistance to immunotherapy in patients with urothelial bladder cancer is traced to specific sets of...

AACR 2021: Copanlisib-rituximab combination cuts lymphoma progression or death by nearly half in CHRONOS-3 trial

AACR 2021: Copanlisib-rituximab combination cuts lymphoma progression or death by nearly half in CHRONOS-3 trial

AACR 2021: Immune-stimulating drug before surgery shows promise in early-stage pancreatic cancer

AACR 2021: Immune-stimulating drug before surgery shows promise in early-stage pancreatic cancer

AACR 2021: Whole-body screening and education in melanoma-prone families may improve early detection rates

AACR 2021: Whole-body screening and education in melanoma-prone families may improve early detection rates

More from ecancer